The historical irony is real: PT-141 exists because Melanotan II worked so well that researchers spent decades trying to extract its best effects into a safer, narrower compound
This collaborative approach ensures infection control and GLP-1 efficacy without unnecessary risk
Clinical Safety Screens Performed MTC personal AND family history in the comorbidity multi-select MEN-2 personal AND family history separately Substance / opioid screen with three-month opiate window + free-text dose, frequency, dates Suicidality and recent suicide attempt as exclusionary opt-out Active cancer treatment and cancer-free-for-five-years exclusionary End-stage kidney and liver disease opt-out Severe GI screen (gastroparesis, blockage, IBD) Pancreatitis history in the multi-select Self-reported blood pressure range and resting heart rate Past 2-month GLP-1 use (semaglutide / tirzepatide / none) No validated PHQ-2 or PHQ-9 depression instrument suicidality is captured as a binary exclusionary opt-out and severe depression is a checkbox on the comorbidity multi-select, but the validated brief screening scale is not used
Behavioral strategies include identifying triggers for sugar cravingswhether emotional, environmental, or habitualand developing alternative responses
They are very tasty, much more like a treat than most protein bars I've tried
.jpg)
